Skip to main content
Premium Trial:

Request an Annual Quote

Gentronix Gets French Tax Credit OK

NEW YORK (GenomeWeb News) – Gentronix today said that it has received a French research tax credit approval for the years 2012-2014.

The credit allows eligible research-intensive French companies who are subject to corporate tax in France the ability to claim tax relief on costs generated in R&D requirements that are outsourced to Gentronix. The firm is based in Manchester, UK, and provides genotoxicity screening products and services.

In a statement, Gentronix Chairman and CEO John Nicholson said the credit approval will provide the firm with greater opportunities to support customers in France.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.